Table 1.
Basic information of patients
| Age (years) | 74.15 ± 7.89[41–93] |
| Male, n (%) | 74(59%) |
| Hypertension | 68(54%) |
| Coronary heart disease | 70(56%) |
| Diabetes | 44(35%) |
| Old myocardial infarction | 41(33%) |
| Myocardial ischemia | 46(37%) |
| Lower extremity atherosclerosis | 58(46%) |
| Cardiac function classification | |
| Class III | 56(44%) |
| Class IV | 70(56%) |
| Lower extremity venous thrombosis | 19(15%) |
| Interstitial venous thrombosis | 14(74%) |
| Popliteal vein thrombosis | 1(5%) |
| Femoral vein thrombosis | 1(5%) |
| Deep vein thrombosis | 1(5%) |
| Small saphenous vein thrombosis | 1(5%) |
| Posterior tibial vein thrombosis | 1(5%) |
| Anticoagulation therapy | |
| Warfarin | 39(31%) |
| New oral anticoagulants (rivaroxaban or dabigatran) | 87(69%) |
| Laboratory data | |
| BNP (pg/L) | 1317.47 ± 929.09 |
| D-DI (µg/L) | 1.74 ± 1.37 |
| vWF (%) | 250.58 ± 88.05 |
Note: D-DI, D-dimer; BNP, B-type natriuretic peptide; vWF, von Willebrand factor